Ajooni Biotech Limited has informed the Exchange about General Updates
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajooni Biotech Limited's Board of Directors, at a meeting held on August 14, 2025, approved the re-appointment of Mr. Gursimran Singh (DIN: 02209675) as Whole Time Director for a period of five years, effective from August 14, 2025. The re-appointment is subject to shareholder approval at the upcoming Annual General Meeting. Mr. Gursimran Singh holds a B.Com and MBA degree, has over 15 years of experience in animal husbandry and crop cultivation, and has been serving as CEO of the company for the past 8 years. He is not related to any existing directors on the Board and is not debarred from holding directorship by SEBI or any other authority.
This is a continuity announcement, with an existing executive being re-appointed for another 5-year term. Shareholders will need to vote on this at the upcoming AGM, but no immediate change in leadership or strategy is expected. Likely a neutral-to-slightly-positive signal on management stability.